PapersFlow Research Brief
Autophagy in Disease and Therapy
Research Guide
What is Autophagy in Disease and Therapy?
Autophagy in Disease and Therapy is the study of autophagy, a cellular self-digestion process, and its molecular mechanisms, dysregulation in diseases such as neurodegenerative conditions, cancer, and infections, along with therapeutic strategies to modulate it.
Autophagy is an intracellular degradative process that delivers cytoplasmic proteins to lysosomes for degradation, with dysfunction implicated in neurodegenerative diseases, infectious diseases, and cancers. "Repertoires of Autophagy in the Pathogenesis of Ocular Diseases" by Li et al. (2015) demonstrated autophagy-related proteins' constitutive expression in ocular tissues and their role in disease pathogenesis. The field encompasses 62,222 works exploring autophagy's interactions with apoptosis, inflammation, and immunity.
Topic Hierarchy
Research Sub-Topics
Autophagy in Neurodegenerative Diseases
This sub-topic examines dysregulated autophagy in Parkinson's, Alzheimer's, and related disorders. Researchers study protein aggregate clearance, mitophagy defects, and therapeutic modulation.
Autophagy and Cancer
Scholars investigate autophagy's dual role as tumor suppressor and promoter across cancer stages. Studies focus on metabolic adaptation, therapy resistance, and selective inhibitors.
Autophagy Regulation by mTOR
This area dissects mTOR pathway control of autophagosome formation via ULK1 and nutrient sensing. Research elucidates signaling crosstalk with AMPK and lysosomal biogenesis.
Mitophagy in Cellular Homeostasis
Researchers study selective mitochondrial autophagy mediated by PINK1/Parkin and receptors. This includes quality control, bioenergetics, and links to inflammation.
Autophagy-Apoptosis Crosstalk
This sub-topic explores molecular interactions between autophagic and apoptotic pathways in cell fate decisions. Studies analyze Beclin-1/Bcl-2 regulation and stress responses.
Why It Matters
Autophagy dysregulation contributes to disease progression in neurodegeneration, cancer, and infections, offering therapeutic targets through modulation. Li et al. (2015) in "Repertoires of Autophagy in the Pathogenesis of Ocular Diseases" linked autophagy impairment to ocular conditions, suggesting interventions to restore lysosomal biogenesis and mitophagy. Levine and Kroemer (2008) in "Autophagy in the Pathogenesis of Disease" established autophagy's broad role across pathologies, while Mizushima et al. (2008) in "Autophagy fights disease through cellular self-digestion" highlighted its protective effects against protein aggregation in Parkinson's disease and tumor suppression in cancer, with 16,332 and 6,357 citations respectively underscoring clinical relevance for therapies balancing autophagy with apoptosis pathways.
Reading Guide
Where to Start
"Autophagy fights disease through cellular self-digestion" by Mizushima et al. (2008) is the first paper to read because it provides a foundational overview of autophagy's protective mechanisms in human diseases with clear examples from neurodegeneration and cancer.
Key Papers Explained
Levine and Kroemer (2008) in "Autophagy in the Pathogenesis of Disease" established autophagy's disease-wide roles, which Mizushima et al. (2008) in "Autophagy fights disease through cellular self-digestion" expanded with self-digestion specifics and disease-fighting evidence. Li et al. (2015) in "Repertoires of Autophagy in the Pathogenesis of Ocular Diseases" built on these by detailing ocular applications, while Kim et al. (2011) in "AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1" provided regulatory mechanisms underpinning therapeutic targeting. Kabeya (2000) in "LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing" offered the molecular marker essential for studying these processes.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current research focuses on autophagy's integration with nonapoptotic deaths like ferroptosis, as in Dixon et al. (2012), and regulatory kinases in disease-specific contexts from Kim et al. (2011). Efforts target ocular and neurodegenerative therapeutics based on Li et al. (2015) pathways, with emphasis on Ulk1 modulation amid 62,222 works.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death | 2012 | Cell | 16.8K | ✓ |
| 2 | Repertoires of Autophagy in the Pathogenesis of Ocular Diseases | 2015 | Cellular Physiology an... | 16.3K | ✓ |
| 3 | Apoptosis: A Review of Programmed Cell Death | 2007 | Toxicologic Pathology | 13.3K | ✓ |
| 4 | The biochemistry of apoptosis | 2000 | Nature | 7.3K | ✕ |
| 5 | Autophagy in the Pathogenesis of Disease | 2008 | Cell | 6.9K | ✓ |
| 6 | Caspases: Enemies Within | 1998 | Science | 6.9K | ✕ |
| 7 | AMPK and mTOR regulate autophagy through direct phosphorylatio... | 2011 | Nature Cell Biology | 6.8K | ✓ |
| 8 | Apoptosis in the Pathogenesis and Treatment of Disease | 1995 | Science | 6.6K | ✕ |
| 9 | LC3, a mammalian homologue of yeast Apg8p, is localized in aut... | 2000 | The EMBO Journal | 6.5K | ✓ |
| 10 | Autophagy fights disease through cellular self-digestion | 2008 | Nature | 6.4K | ✓ |
Frequently Asked Questions
What is autophagy?
Autophagy is an important intracellular degradative process that delivers cytoplasmic proteins to lysosome for degradation. Li et al. (2015) in "Repertoires of Autophagy in the Pathogenesis of Ocular Diseases" note its role in maintaining cellular homeostasis. Dysfunction leads to accumulation of damaged components.
How does autophagy relate to ocular diseases?
Autophagy-related proteins are constitutively expressed in ocular tissues and participate in disease pathogenesis. "Repertoires of Autophagy in the Pathogenesis of Ocular Diseases" by Li et al. (2015) showed impaired autophagy contributes to neurodegeneration and cancer in the eye. Therapeutic modulation targets these pathways.
What is the role of autophagy in general disease pathogenesis?
Autophagy fights disease through cellular self-digestion by degrading damaged organelles and proteins. Mizushima et al. (2008) in "Autophagy fights disease through cellular self-digestion" described its protection against neurodegeneration and infections. Levine and Kroemer (2008) in "Autophagy in the Pathogenesis of Disease" linked its dysregulation to cancer and inflammation.
How do AMPK and mTOR regulate autophagy?
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Kim et al. (2011) in "AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1" demonstrated AMPK activates and mTOR inhibits Ulk1 to control autophagosome formation. This mechanism integrates nutrient sensing with autophagy induction.
What is the connection between autophagy and apoptosis?
Autophagy and apoptosis interact in disease contexts, with autophagy often counterbalancing apoptotic cell death. Dixon et al. (2012) in "Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death" distinguished nonapoptotic pathways like ferroptosis from autophagy. Elmore (2007) in "Apoptosis: A Review of Programmed Cell Death" outlined apoptosis as energy-dependent, contrasting with autophagy's degradative role.
What are key markers of autophagy?
LC3 is a mammalian homologue of yeast Apg8p localized in autophagosome membranes after processing. Kabeya (2000) in "LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing" identified LC3 as a marker for autophagosome detection. This enables quantification of autophagy flux in disease studies.
Open Research Questions
- ? How can autophagy be selectively modulated to treat Parkinson's disease without disrupting normal cellular homeostasis?
- ? What are the precise molecular interactions between autophagy impairment and ferroptosis in cancer progression?
- ? In which ocular diseases does autophagy dysfunction predominate, and what therapeutic compounds restore it?
- ? How do Ulk1 phosphorylation dynamics by AMPK and mTOR differ across inflammatory and infectious diseases?
- ? What role does LC3 processing play in autophagy's failure during neurodegeneration?
Recent Trends
The field maintains 62,222 works on autophagy in disease and therapy, with high citation persistence for foundational papers like Dixon et al. at 16,751 citations and Li et al. (2015) at 16,332, reflecting sustained focus on nonapoptotic deaths and ocular pathogenesis amid interactions with apoptosis and immunity.
2012Research Autophagy in Disease and Therapy with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Autophagy in Disease and Therapy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers